We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.16B
AUM Growth
+$372M
Cap. Flow
+$132M
Cap. Flow %
11.39%
Top 10 Hldgs %
68.38%
Holding
232
New
129
Increased
24
Reduced
12
Closed
56

Top Buys

Rank Stock Value
1
SANA icon
Sana Biotechnology
SANA
+$72.8M
2
PBR.A icon
Petrobras Class A
PBR.A
+$20.9M
3
AMP icon
Ameriprise Financial
AMP
+$11.4M
4
MET icon
MetLife
MET
+$10.1M
5
WFC icon
Wells Fargo
WFC
+$7.59M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$114M
2
MU icon
Micron Technology
MU
+$7.77M
3
UDR icon
UDR
UDR
+$5.92M
4
EQH icon
Equitable Holdings
EQH
+$4.95M
5
LRCX icon
Lam Research
LRCX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 61.94%
2 Financials 15.05%
3 Materials 5.33%
4 Technology 3.84%
5 Energy 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWET
126
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
$483K 0.04%
+49,851
New +$484K
ARBG
127
DELISTED
Aequi Acquisition Corp
ARBG
$464K 0.04%
+47,570
New +$465K
GCAC
128
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
$459K 0.04%
+47,306
New +$461K
CAHC
129
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
$445K 0.04%
+45,000
New +$445K
APGN
130
DELISTED
Apexigen, Inc. Common Stock
APGN
$406K 0.04%
+40,961
New +$406K
CND
131
DELISTED
Concord Acquisition Corp.
CND
$405K 0.03%
41,097
+15,597
+61% +$153K
SOND
132
DELISTED
Sonder
SOND
$396K 0.03%
+2,000
New +$397K
EAC
133
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$291K 0.03%
30,144
+4,344
+17% +$42.2K
FREE
134
CALL
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$290K 0.03%
+20,000
New +$267K
FCAC
135
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$279K 0.02%
+30,039
New +$299K
WARR
136
DELISTED
Warrior Technologies Acquisition Company
WARR
$260K 0.02%
+26,845
New +$261K
PRST
137
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$252K 0.02%
+25,300
New +$252K
RDBX
138
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
$252K 0.02%
+25,263
New +$251K
BTTX
139
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$251K 0.02%
+25,300
New +$251K
KWAC
140
DELISTED
Kingswood Acquisition Corp.
KWAC
$251K 0.02%
+25,000
New +$251K
YSAC
141
DELISTED
Yellowstone Acquisition Company
YSAC
$251K 0.02%
+24,983
New +$251K
BREZ
142
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$250K 0.02%
+24,960
New +$250K
VHAQ
143
DELISTED
Viveon Health Acquisition Corp.
VHAQ
$250K 0.02%
+25,282
New +$251K
NIR
144
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$250K 0.02%
+25,504
New +$249K
ACKIT
145
DELISTED
Ackrell SPAC Partners I Co Subunits
ACKIT
$250K 0.02%
+25,200
New +$251K
ETAC
146
DELISTED
E.Merge Technology Acquisition Corp. Class A Common Stock
ETAC
$249K 0.02%
+25,529
New +$250K
GIG
147
DELISTED
GigCapital4, Inc. Common stock
GIG
$246K 0.02%
+25,000
New +$244K
OSCR icon
148
CALL
Oscar Health
OSCR
$9.41B
$215K 0.02%
+10,000
New +$239K
CPNG icon
149
CALL
Coupang
CPNG
$29.3B
$209K 0.02%
+5,000
New +$205K
PKBO
150
DELISTED
Peak Bio, Inc. Common Stock
PKBO
$203K 0.02%
+20,924
New +$204K
4 5
6
7 8

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q2 2021 Portfolio in Review

As of Q2 2021, Crestline Management held 232 positions worth $1.16B, up 47% from $788M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Crestline Management deployed $132M of net new capital in Q2 2021, opening 129 new positions and adding to 24 existing holdings. Its largest new stake was Sana Biotechnology: 3,210,937 shares worth $63.1M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 72% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $114M trimmed.

  • Crestline Management's largest Q2 2021 buy was Sana Biotechnology: 3,210,937 shares worth $63.1M.
  • Crestline Management added most to Travelers Companies in Q2 2021, an estimated $6.82M increase.
  • Crestline Management's biggest Q2 2021 reduction was Denali Therapeutics, cutting an estimated $114M.
  • Crestline Management fully exited Micron Technology in Q2 2021, selling an estimated $7.77M.
  • Crestline Management's ten largest holdings make up 68% of its $1.16B portfolio in Q2 2021.
  • Crestline Management opened 129 new positions and closed 56 in Q2 2021.
  • Crestline Management's portfolio value rose 47% quarter-over-quarter to $1.16B.

Based on Crestline Management's 13F filing for Q2 2021, filed 13 Aug 2021.